G360: MIGS uninhibited: Thinking outside the box

Video
Conference|Glaucoma 360

Oluwatosin Smith, MD, reviews different applications of minimally invasive glaucoma surgeries (MIGS) to find the best option, with the best outcome, for every patient.

Oluwatosin Smith, MD, Associate Professor of the Department of Ophthalmology at the University of Texas speaks with Optometry Times'® Sheryl Stevenson on her presentation "MIGS uninhibited: Thinking outside the box" during the 2022 Glaucoma 360 meeting.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Subscribe Now!
Recent Videos
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
At CIME 2025, Selina McGee, OD, FAAO, says some patients underestimate oculoplastic care. She stands in front of a sign that says Controversies in Modern Eye Care 2025.
Dana Shannon, OD, FAAO, shares pearls on spotting red flags in need of referral and enhancing patient care with follow-up compliance.
Dana Shannon, OD, FAAO, detailed a lecture she gave at the NOA Midwestern Symposium earlier this month.
CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
Dr. Nate Lighthizer shares key takeaways from the SECO Showcase on anterior segment technology and full laser certification course offered at SECO.
Shan Lin, MD, and John Berdahl, MD, share their perspectives as ophthalmologists regarding the importance of comanagement.
Related Content
Two scientists discussing data in lab Image credit: AdobeStock/peopleimages.com

ARVO 2025: Perfuse Therapeutics announces positive results from phase 1/2a trial of PER-001, an intravitreal implant for glaucoma

Jordana Joy, Associate Editor
May 9th 2025
Article
Expanding the treatment arsenal in glaucoma management

Expanding the treatment arsenal in glaucoma management

Melissa Tawa, OD, FAAO;Deborah Ristvedt, DO;Inder Paul Singh, MD;Arsham Sheybani, MD
August 31st 2024
Podcast
SpyGlass Pharma unveils 18-month data of bimatoprost-eluting IOL - Image credit: ©Roman—stock.adobe.com

18-month data of IOL-mounted drug delivery platform shows impressive results in IOP, visual acuity

Emily Kaiser Maharjan, Assistant Managing Editor
May 1st 2025
Article
Optometry Times You and Eye

You and Eye: What optometrists need to know about low vision

Miriam Korik, OD;Emily Kaiser Maharjan, Assistant Managing Editor
March 13th 2024
Podcast
Dr Neda Shamie highlights some of her most highly anticipated symposia from the upcoming Controversies in Modern Eye Care meeting.

Q&A: The education at the 19th Annual Controversies in Modern Eye Care is a force to be reckoned with

Neda Shamie, MD;Sheryl Stevenson, Eye Care Group Editorial Director;Emily Kaiser Maharjan, Assistant Managing Editor
April 22nd 2025
Article
Doctor writing on clipboard Image credit: AdobeStock/KirstenD/peopleimages.com

Saudi Arabian study finds knowledge gaps in public understanding of glaucoma and cataracts

Martin David Harp, Editor, Ophthalmology Times;Jordana Joy, Associate Editor
April 18th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.